mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |